The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy
- PMID: 10614912
- DOI: 10.1055/s-0029-1212175
The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy
Abstract
Thyroid-associated orbitopathy (TAO) involves a remodelling of the connective tissue in the orbit, accumulation of the non-sulfated glycosaminoglycan, hyaluronan, and often intense inflammation. Orbital fibroblasts exhibit a remarkable susceptibility to various actions of pro-inflammatory cytokines and these molecular interactions we hypothesize are the basis for the peculiar tissue changes seen in ophthalmopathy, including the accumulation of hyaluronan. We have found that several pro-inflammatory cytokines can dramatically induce prostaglandin endoperoxide H synthase-2 (PGHS-2), the inflammatory cyclooxygenase, and that this induction results in a substantial increase in PGE2 production. The increase in cyclooxygenase expression and PGE2 synthesis can be blocked with glucocorticoids. The magnitude of the up-regulation of the prostanoid biosynthetic machinery in orbital fibroblasts from patients with ophthalmopathy was considerably greater than that found in dermal cultures or in orbital fibroblasts from normal tissue. Orbital fibroblasts, unlike most fibroblasts, express CD40 and when that surface receptor is cross-linked with CD154, its natural ligand, a number of inflammation-related genes are activated. These include IL-1alpha, IL-6, IL-8 and PGHS-2. It would appear that orbital fibroblasts, especially those from patients with ophthalmopathy, exhibit several exaggerated responses to pro-inflammatory signals and that those cellular actions could provide the molecular basis for orbital tissue remodelling.
Similar articles
-
Activation of human orbital fibroblasts through CD40 engagement results in a dramatic induction of hyaluronan synthesis and prostaglandin endoperoxide H synthase-2 expression. Insights into potential pathogenic mechanisms of thyroid-associated ophthalmopathy.J Biol Chem. 1998 Nov 6;273(45):29615-25. doi: 10.1074/jbc.273.45.29615. J Biol Chem. 1998. PMID: 9792671
-
Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts.Exp Cell Res. 1998 Dec 15;245(2):360-7. doi: 10.1006/excr.1998.4273. Exp Cell Res. 1998. PMID: 9851877
-
Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation.J Biol Chem. 1996 Sep 13;271(37):22718-28. J Biol Chem. 1996. PMID: 8798446
-
Unique properties of orbital connective tissue underlie its involvement in Graves' disease.Minerva Endocrinol. 2003 Sep;28(3):213-22. Minerva Endocrinol. 2003. PMID: 14605603 Review.
-
Orbital fibroblasts exhibit a novel pattern of responses to proinflammatory cytokines: potential basis for the pathogenesis of thyroid-associated ophthalmopathy.Thyroid. 2002 Mar;12(3):197-203. doi: 10.1089/105072502753600133. Thyroid. 2002. PMID: 11952039 Review.
Cited by
-
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.Invest Ophthalmol Vis Sci. 2014 Mar 20;55(3):1735-48. doi: 10.1167/iovs.14-14002. Invest Ophthalmol Vis Sci. 2014. PMID: 24651704 Free PMC article. Review.
-
Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation.PPAR Res. 2008;2008:895901. doi: 10.1155/2008/895901. PPAR Res. 2008. PMID: 18354731 Free PMC article.
-
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.Invest Ophthalmol Vis Sci. 2009 May;50(5):2262-8. doi: 10.1167/iovs.08-2328. Epub 2008 Dec 30. Invest Ophthalmol Vis Sci. 2009. PMID: 19117935 Free PMC article.
-
In Vivo Effects of Retrobulbar Bimatoprost Injection on Orbital Fat.Ophthalmic Plast Reconstr Surg. 2018 May/Jun;34(3):201-204. doi: 10.1097/IOP.0000000000000907. Ophthalmic Plast Reconstr Surg. 2018. PMID: 28369019 Free PMC article.
-
Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.Thyroid. 2008 Aug;18(8):911-4. doi: 10.1089/thy.2007.0325. Thyroid. 2008. PMID: 18651822 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials